【性    状】本品内容物为砖红色或暗红色的结晶性粉末。

【Description】The contents is brick red or dark red crystalline powder.


【适 应 症】

    1. 本品与其他抗结核药联合用于各种结核病的初治与复治,但不宜用于结核性脑膜炎的治疗。

    2. 适合医务人员直接观察下的短程化疗。

    3. 亦可用于非结核性分枝杆菌感染的治疗。

4. 与其他抗麻风药联合用于麻风治疗可能有效。

【Indications】

1. This product is used for initial treatment and retreatment of all kinds of tuberculosis with other anti-TB drugs, but not for the treatment of tuberculous meningitis.

2. Rifapentine capsules is Suitable for Directly Observed Treatment Short course.

3. Rifapentine capsules is also can be used in the treatment of non tuberculous mycobacteria infection.

4. Rifapentine capsules may be effective for treatment of leprosy with other anti-leprosy drug.


【规    格】  0.15g;0.3g 

【Specification】0.15g;0.3g

【用法用量】口服,抗结核。成人一次0.6g(4粒或2粒)(体重<55kg者应酌减),一日1次,空腹时(餐前1小时)用水送服;一周服药1~2次。需与其他抗结核药联合应用,肺结核初始患者其疗程一般为6~9个月。

【 Dosage 】Oral, anti-TB. Adult, 0.6g every time, one time a day (4 or 2 capsules) (The dosage for the patient whose body weight is less than 55kg should be reduced). Dose with water an hour before meal. Dose 1 ~ 2 times a week. Should be dosed with other anti-tuberculosis medicine. Course of Initial treatment of phthisis is generally 6 ~ 9 months.


【包   装】

药用塑料瓶包装,20粒/瓶。(0.15g;0.30g)

药用塑料瓶包装,50粒/瓶。(0.15g)

铝塑泡罩板包装,10粒/板×2板/盒。(0.15g)

【Packing】

Medicinal Plastic Bottles: 20capsules/bottle(0.15g;0.30g), 

Medicinal Plastic Bottles: 50 capsules/bottle(0.15g); 

Aluminum Plastic bubble cap tray :10 capsules/board×2 boards/box(0.15g)


【有 效 期】24个月

【Validity】24 months


【执行标准】WS1-(X-283)-2004Z

【Executive standard】WS1-(X-283)-2004Z


【批准文号】国药准字H10940012; 国药准字H10940011

【Approval Number】SFDA Approval No. H10940012; SFDA Approval No. H10940011



客服1

客服2